TY  - JOUR
AU  - Cramer, Daniel W
AU  - Fichorova, Raina N
AU  - Terry, Kathryn L
AU  - Yamamoto, Hidemi
AU  - Vitonis, Allison F
AU  - Ardanaz, Eva
AU  - Aune, Dagfinn
AU  - Boeing, Heiner
AU  - Brändstedt, Jenny
AU  - Boutron-Ruault, Marie-Christine
AU  - Chirlaque, Maria-Dolores
AU  - Dorronsoro, Miren
AU  - Dossus, Laure
AU  - Duell, Eric J
AU  - Gram, Inger T
AU  - Gunter, Marc
AU  - Hansen, Louise
AU  - Idahl, Annika
AU  - Johnson, Theron
AU  - Khaw, Kay-Tee
AU  - Krogh, Vittorio
AU  - Kvaskoff, Marina
AU  - Mattiello, Amalia
AU  - Matullo, Giuseppe
AU  - Merritt, Melissa A
AU  - Nodin, Björn
AU  - Orfanos, Philippos
AU  - Onland-Moret, N Charlotte
AU  - Palli, Domenico
AU  - Peppa, Eleni
AU  - Quirós, J Ramón
AU  - Sanchez-Perez, Maria-Jose
AU  - Severi, Gianluca
AU  - Tjønneland, Anne
AU  - Travis, Ruth C
AU  - Trichopoulou, Antonia
AU  - Tumino, Rosario
AU  - Weiderpass, Elisabete
AU  - Fortner, Renée T
AU  - Kaaks, Rudolf
PY  - 2018
DO  - 10.1158/1055-9965.EPI-17-0744
UR  - http://hdl.handle.net/10668/12355
T2  - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
AB  - Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and generate antibodies against them, but their impact on epithelial ovarian cancer (EOC) risk has not been fully defined.Methods: CA15.3, CA125, and IgG1...
LA  - en
KW  - Adult
KW  - Aged
KW  - Biomarkers, Tumor
KW  - CA-125 Antigen
KW  - Case-Control Studies
KW  - Cohort Studies
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - Prospective Studies
KW  - Risk Factors
TI  - Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort.
TY  - research article
VL  - 27
ER  -